nodes	percent_of_prediction	percent_of_DWPC	metapath
Propofol—UGT1A1—urine—nephrolithiasis	0.0341	0.0995	CbGeAlD
Propofol—Stiffness—Hydrochlorothiazide—nephrolithiasis	0.0277	0.0663	CcSEcCtD
Propofol—Arrhythmia supraventricular—Hydrochlorothiazide—nephrolithiasis	0.0271	0.065	CcSEcCtD
Propofol—UGT1A8—renal system—nephrolithiasis	0.0192	0.0559	CbGeAlD
Propofol—UGT1A8—kidney—nephrolithiasis	0.0185	0.0541	CbGeAlD
Propofol—CYP2C19—urine—nephrolithiasis	0.0185	0.0539	CbGeAlD
Propofol—ALB—Scavenging of heme from plasma—AMBP—nephrolithiasis	0.0176	0.0736	CbGpPWpGaD
Propofol—FAAH—nephron tubule—nephrolithiasis	0.0153	0.0447	CbGeAlD
Propofol—CYP1A2—urine—nephrolithiasis	0.0151	0.044	CbGeAlD
Propofol—Hyperlipidaemia—Hydrochlorothiazide—nephrolithiasis	0.0146	0.035	CcSEcCtD
Propofol—CYP2C9—urine—nephrolithiasis	0.0143	0.0418	CbGeAlD
Propofol—FAAH—renal system—nephrolithiasis	0.0139	0.0406	CbGeAlD
Propofol—Ventricular fibrillation—Hydrochlorothiazide—nephrolithiasis	0.0137	0.0329	CcSEcCtD
Propofol—CYP2E1—urine—nephrolithiasis	0.0136	0.0396	CbGeAlD
Propofol—FAAH—cortex of kidney—nephrolithiasis	0.0131	0.0383	CbGeAlD
Propofol—Stinging—Hydrochlorothiazide—nephrolithiasis	0.013	0.0311	CcSEcCtD
Propofol—UGT1A9—renal system—nephrolithiasis	0.0122	0.0355	CbGeAlD
Propofol—Rhabdomyolysis—Hydrochlorothiazide—nephrolithiasis	0.0119	0.0285	CcSEcCtD
Propofol—UGT1A9—kidney—nephrolithiasis	0.0118	0.0343	CbGeAlD
Propofol—Musculoskeletal stiffness—Hydrochlorothiazide—nephrolithiasis	0.0117	0.0281	CcSEcCtD
Propofol—UGT1A8—Phase II conjugation—SLC26A1—nephrolithiasis	0.011	0.046	CbGpPWpGaD
Propofol—CYP3A4—urine—nephrolithiasis	0.0109	0.0319	CbGeAlD
Propofol—CYP2D6—urine—nephrolithiasis	0.0108	0.0314	CbGeAlD
Propofol—Ventricular tachycardia—Hydrochlorothiazide—nephrolithiasis	0.0105	0.0252	CcSEcCtD
Propofol—Hyperkalaemia—Hydrochlorothiazide—nephrolithiasis	0.0103	0.0248	CcSEcCtD
Propofol—Wheezing—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0245	CcSEcCtD
Propofol—Blood urea increased—Hydrochlorothiazide—nephrolithiasis	0.00994	0.0238	CcSEcCtD
Propofol—Pulmonary oedema—Hydrochlorothiazide—nephrolithiasis	0.00937	0.0224	CcSEcCtD
Propofol—SCN4A—renal system—nephrolithiasis	0.00904	0.0264	CbGeAlD
Propofol—SCN4A—kidney—nephrolithiasis	0.00874	0.0255	CbGeAlD
Propofol—UGT1A1—renal system—nephrolithiasis	0.00834	0.0243	CbGeAlD
Propofol—UGT1A1—kidney—nephrolithiasis	0.00806	0.0235	CbGeAlD
Propofol—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.00806	0.0193	CcSEcCtD
Propofol—UGT1A6—Phase II conjugation—SLC26A1—nephrolithiasis	0.00803	0.0335	CbGpPWpGaD
Propofol—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.00764	0.0183	CcSEcCtD
Propofol—SCN2A—cortex of kidney—nephrolithiasis	0.00754	0.022	CbGeAlD
Propofol—Affect lability—Hydrochlorothiazide—nephrolithiasis	0.00752	0.018	CcSEcCtD
Propofol—Mood swings—Hydrochlorothiazide—nephrolithiasis	0.00724	0.0173	CcSEcCtD
Propofol—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.00716	0.0171	CcSEcCtD
Propofol—ALB—Binding and Uptake of Ligands by Scavenger Receptors—AMBP—nephrolithiasis	0.00704	0.0294	CbGpPWpGaD
Propofol—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.00688	0.0165	CcSEcCtD
Propofol—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.00647	0.0155	CcSEcCtD
Propofol—UGT1A8—Biological oxidations—SLC26A1—nephrolithiasis	0.00644	0.0269	CbGpPWpGaD
Propofol—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.00596	0.0143	CcSEcCtD
Propofol—GABRA2—cortex of kidney—nephrolithiasis	0.00585	0.0171	CbGeAlD
Propofol—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.0058	0.0139	CcSEcCtD
Propofol—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.00579	0.0139	CcSEcCtD
Propofol—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00577	0.0138	CcSEcCtD
Propofol—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.00577	0.0138	CcSEcCtD
Propofol—CYP1B1—nephron tubule—nephrolithiasis	0.00567	0.0165	CbGeAlD
Propofol—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.00538	0.0129	CcSEcCtD
Propofol—UGT1A6—NRF2 pathway—SLC2A9—nephrolithiasis	0.00536	0.0224	CbGpPWpGaD
Propofol—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00525	0.0126	CcSEcCtD
Propofol—CYP1B1—renal system—nephrolithiasis	0.00515	0.015	CbGeAlD
Propofol—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.00509	0.0122	CcSEcCtD
Propofol—CYP1B1—kidney—nephrolithiasis	0.00498	0.0145	CbGeAlD
Propofol—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00493	0.0118	CcSEcCtD
Propofol—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00491	0.0117	CcSEcCtD
Propofol—CYP1B1—cortex of kidney—nephrolithiasis	0.00485	0.0142	CbGeAlD
Propofol—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00472	0.0113	CcSEcCtD
Propofol—UGT1A6—Biological oxidations—SLC26A1—nephrolithiasis	0.0047	0.0196	CbGpPWpGaD
Propofol—Erythema—Hydrochlorothiazide—nephrolithiasis	0.0046	0.011	CcSEcCtD
Propofol—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00451	0.0108	CcSEcCtD
Propofol—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00442	0.0106	CcSEcCtD
Propofol—GABRB2—Ion channel transport—CLCN5—nephrolithiasis	0.00435	0.0182	CbGpPWpGaD
Propofol—GABRB2—Ion channel transport—CLCN4—nephrolithiasis	0.00435	0.0182	CbGpPWpGaD
Propofol—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00431	0.0103	CcSEcCtD
Propofol—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00423	0.0101	CcSEcCtD
Propofol—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.0042	0.0101	CcSEcCtD
Propofol—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00413	0.00988	CcSEcCtD
Propofol—GABRA2—Ion channel transport—CLCN4—nephrolithiasis	0.00408	0.017	CbGpPWpGaD
Propofol—GABRA2—Ion channel transport—CLCN5—nephrolithiasis	0.00408	0.017	CbGpPWpGaD
Propofol—GABRB3—Ion channel transport—CLCN5—nephrolithiasis	0.00406	0.0169	CbGpPWpGaD
Propofol—GABRB3—Ion channel transport—CLCN4—nephrolithiasis	0.00406	0.0169	CbGpPWpGaD
Propofol—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00404	0.00968	CcSEcCtD
Propofol—Cough—Hydrochlorothiazide—nephrolithiasis	0.00402	0.00961	CcSEcCtD
Propofol—GABRG2—Ion channel transport—CLCN5—nephrolithiasis	0.00398	0.0166	CbGpPWpGaD
Propofol—GABRG2—Ion channel transport—CLCN4—nephrolithiasis	0.00398	0.0166	CbGpPWpGaD
Propofol—CYP2C8—renal system—nephrolithiasis	0.00395	0.0115	CbGeAlD
Propofol—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00392	0.00938	CcSEcCtD
Propofol—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00392	0.00938	CcSEcCtD
Propofol—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.0039	0.00934	CcSEcCtD
Propofol—CYP2B6—nephron tubule—nephrolithiasis	0.00389	0.0114	CbGeAlD
Propofol—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00383	0.00917	CcSEcCtD
Propofol—CYP2C8—kidney—nephrolithiasis	0.00381	0.0111	CbGeAlD
Propofol—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00379	0.00906	CcSEcCtD
Propofol—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00376	0.00899	CcSEcCtD
Propofol—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00376	0.00899	CcSEcCtD
Propofol—Shock—Hydrochlorothiazide—nephrolithiasis	0.00369	0.00884	CcSEcCtD
Propofol—CYP1A2—renal system—nephrolithiasis	0.00369	0.0108	CbGeAlD
Propofol—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00367	0.00877	CcSEcCtD
Propofol—CYP2E1—nephron tubule—nephrolithiasis	0.00365	0.0107	CbGeAlD
Propofol—CYP1A1—renal system—nephrolithiasis	0.00364	0.0106	CbGeAlD
Propofol—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00363	0.00869	CcSEcCtD
Propofol—UGT1A1—Phase II conjugation—SLC26A1—nephrolithiasis	0.00356	0.0149	CbGpPWpGaD
Propofol—UGT1A9—Phase II conjugation—SLC26A1—nephrolithiasis	0.00356	0.0149	CbGpPWpGaD
Propofol—CYP2B6—renal system—nephrolithiasis	0.00354	0.0103	CbGeAlD
Propofol—CYP1A1—kidney—nephrolithiasis	0.00352	0.0103	CbGeAlD
Propofol—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00351	0.0084	CcSEcCtD
Propofol—GABRA1—Ion channel transport—CLCN5—nephrolithiasis	0.00348	0.0145	CbGpPWpGaD
Propofol—GABRA1—Ion channel transport—CLCN4—nephrolithiasis	0.00348	0.0145	CbGpPWpGaD
Propofol—CYP2B6—kidney—nephrolithiasis	0.00342	0.00999	CbGeAlD
Propofol—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00342	0.00819	CcSEcCtD
Propofol—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.0034	0.00813	CcSEcCtD
Propofol—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00337	0.00807	CcSEcCtD
Propofol—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00335	0.00801	CcSEcCtD
Propofol—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00334	0.00799	CcSEcCtD
Propofol—CYP2E1—renal system—nephrolithiasis	0.00332	0.0097	CbGeAlD
Propofol—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00324	0.00775	CcSEcCtD
Propofol—CYP2E1—kidney—nephrolithiasis	0.00321	0.00937	CbGeAlD
Propofol—Pain—Hydrochlorothiazide—nephrolithiasis	0.00321	0.00769	CcSEcCtD
Propofol—CYP2E1—cortex of kidney—nephrolithiasis	0.00313	0.00913	CbGeAlD
Propofol—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00309	0.00741	CcSEcCtD
Propofol—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00298	0.00714	CcSEcCtD
Propofol—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00297	0.00711	CcSEcCtD
Propofol—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00297	0.00711	CcSEcCtD
Propofol—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00269	0.00645	CcSEcCtD
Propofol—CYP3A4—renal system—nephrolithiasis	0.00267	0.0078	CbGeAlD
Propofol—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00266	0.00636	CcSEcCtD
Propofol—CYP2C18—Biological oxidations—SLC26A1—nephrolithiasis	0.00264	0.011	CbGpPWpGaD
Propofol—CYP2D6—renal system—nephrolithiasis	0.00263	0.00768	CbGeAlD
Propofol—CYP3A4—kidney—nephrolithiasis	0.00258	0.00754	CbGeAlD
Propofol—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00257	0.00615	CcSEcCtD
Propofol—CYP2D6—kidney—nephrolithiasis	0.00254	0.00742	CbGeAlD
Propofol—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00248	0.00594	CcSEcCtD
Propofol—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00239	0.00571	CcSEcCtD
Propofol—UGT1A1—NRF2 pathway—SLC2A9—nephrolithiasis	0.00238	0.00992	CbGpPWpGaD
Propofol—UGT1A9—NRF2 pathway—SLC2A9—nephrolithiasis	0.00238	0.00992	CbGpPWpGaD
Propofol—Rash—Hydrochlorothiazide—nephrolithiasis	0.00237	0.00567	CcSEcCtD
Propofol—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00237	0.00566	CcSEcCtD
Propofol—Headache—Hydrochlorothiazide—nephrolithiasis	0.00235	0.00563	CcSEcCtD
Propofol—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00223	0.00534	CcSEcCtD
Propofol—UGT1A9—Biological oxidations—SLC26A1—nephrolithiasis	0.00208	0.0087	CbGpPWpGaD
Propofol—UGT1A1—Biological oxidations—SLC26A1—nephrolithiasis	0.00208	0.0087	CbGpPWpGaD
Propofol—CYP1B1—Biological oxidations—SLC26A1—nephrolithiasis	0.00194	0.00811	CbGpPWpGaD
Propofol—CYP2A6—NRF2 pathway—SLC2A9—nephrolithiasis	0.00183	0.00765	CbGpPWpGaD
Propofol—CYP2A6—Biological oxidations—SLC26A1—nephrolithiasis	0.00161	0.00671	CbGpPWpGaD
Propofol—GABRB2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00152	0.00633	CbGpPWpGaD
Propofol—GABRB2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00152	0.00633	CbGpPWpGaD
Propofol—UGT1A8—Metabolism—GRHPR—nephrolithiasis	0.00145	0.00607	CbGpPWpGaD
Propofol—GABRA2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00142	0.00593	CbGpPWpGaD
Propofol—GABRA2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00142	0.00593	CbGpPWpGaD
Propofol—GABRB3—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00141	0.00589	CbGpPWpGaD
Propofol—GABRB3—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00141	0.00589	CbGpPWpGaD
Propofol—GABRG2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00139	0.00579	CbGpPWpGaD
Propofol—GABRG2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00139	0.00579	CbGpPWpGaD
Propofol—GABRB2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00135	0.00564	CbGpPWpGaD
Propofol—CYP1A2—Phase II conjugation—SLC26A1—nephrolithiasis	0.0013	0.00545	CbGpPWpGaD
Propofol—CYP2B6—Biological oxidations—SLC26A1—nephrolithiasis	0.0013	0.00541	CbGpPWpGaD
Propofol—UGT1A8—Metabolism—AGXT—nephrolithiasis	0.0013	0.00541	CbGpPWpGaD
Propofol—CYP2E1—Biological oxidations—SLC26A1—nephrolithiasis	0.00127	0.0053	CbGpPWpGaD
Propofol—GABRA2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00127	0.00529	CbGpPWpGaD
Propofol—GABRB3—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00126	0.00525	CbGpPWpGaD
Propofol—GABRB2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00124	0.00516	CbGpPWpGaD
Propofol—GABRB2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00124	0.00516	CbGpPWpGaD
Propofol—GABRG2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00124	0.00516	CbGpPWpGaD
Propofol—ALB—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00122	0.00508	CbGpPWpGaD
Propofol—GABRA1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00121	0.00506	CbGpPWpGaD
Propofol—GABRA1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00121	0.00506	CbGpPWpGaD
Propofol—CYP1A1—Biological oxidations—SLC26A1—nephrolithiasis	0.0012	0.005	CbGpPWpGaD
Propofol—GABRA2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00116	0.00484	CbGpPWpGaD
Propofol—GABRA2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00116	0.00484	CbGpPWpGaD
Propofol—GABRB3—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00115	0.0048	CbGpPWpGaD
Propofol—GABRB3—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00115	0.0048	CbGpPWpGaD
Propofol—GABRG2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00113	0.00472	CbGpPWpGaD
Propofol—GABRG2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00113	0.00472	CbGpPWpGaD
Propofol—ALB—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00111	0.00465	CbGpPWpGaD
Propofol—ALB—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00111	0.00465	CbGpPWpGaD
Propofol—UGT1A8—Metabolism—SLC26A1—nephrolithiasis	0.0011	0.0046	CbGpPWpGaD
Propofol—UGT1A8—Metabolism—APRT—nephrolithiasis	0.0011	0.0046	CbGpPWpGaD
Propofol—CYP2C8—Biological oxidations—SLC26A1—nephrolithiasis	0.0011	0.00458	CbGpPWpGaD
Propofol—GABRA1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00108	0.00451	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—GRHPR—nephrolithiasis	0.00106	0.00443	CbGpPWpGaD
Propofol—GABRA1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000988	0.00412	CbGpPWpGaD
Propofol—GABRA1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000988	0.00412	CbGpPWpGaD
Propofol—CYP2C19—Biological oxidations—SLC26A1—nephrolithiasis	0.000979	0.00409	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—AGXT—nephrolithiasis	0.000945	0.00395	CbGpPWpGaD
Propofol—GABRB2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000936	0.00391	CbGpPWpGaD
Propofol—GABRB2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000936	0.00391	CbGpPWpGaD
Propofol—CYP2D6—Biological oxidations—SLC26A1—nephrolithiasis	0.000901	0.00376	CbGpPWpGaD
Propofol—CYP2C9—Biological oxidations—SLC26A1—nephrolithiasis	0.000893	0.00373	CbGpPWpGaD
Propofol—GABRA2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000878	0.00366	CbGpPWpGaD
Propofol—GABRA2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000878	0.00366	CbGpPWpGaD
Propofol—GABRB3—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000872	0.00364	CbGpPWpGaD
Propofol—GABRB3—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000872	0.00364	CbGpPWpGaD
Propofol—GABRB2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000871	0.00363	CbGpPWpGaD
Propofol—GABRB2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000871	0.00363	CbGpPWpGaD
Propofol—GABRG2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000856	0.00358	CbGpPWpGaD
Propofol—GABRG2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000856	0.00358	CbGpPWpGaD
Propofol—ALB—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.000843	0.00352	CbGpPWpGaD
Propofol—ALB—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.000843	0.00352	CbGpPWpGaD
Propofol—GABRA2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000816	0.00341	CbGpPWpGaD
Propofol—GABRA2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000816	0.00341	CbGpPWpGaD
Propofol—GABRB3—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000811	0.00338	CbGpPWpGaD
Propofol—GABRB3—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000811	0.00338	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—APRT—nephrolithiasis	0.000804	0.00335	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—SLC26A1—nephrolithiasis	0.000804	0.00335	CbGpPWpGaD
Propofol—GABRG2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000796	0.00332	CbGpPWpGaD
Propofol—GABRG2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000796	0.00332	CbGpPWpGaD
Propofol—ALB—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.000796	0.00332	CbGpPWpGaD
Propofol—UGT1A8—Metabolism—AQP1—nephrolithiasis	0.000785	0.00328	CbGpPWpGaD
Propofol—ALB—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.000784	0.00327	CbGpPWpGaD
Propofol—ALB—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.000784	0.00327	CbGpPWpGaD
Propofol—GABRB2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000776	0.00324	CbGpPWpGaD
Propofol—GABRB2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000776	0.00324	CbGpPWpGaD
Propofol—CYP1A2—Biological oxidations—SLC26A1—nephrolithiasis	0.000763	0.00319	CbGpPWpGaD
Propofol—GABRB3—BDNF signaling pathway—SPP1—nephrolithiasis	0.000757	0.00316	CbGpPWpGaD
Propofol—GABRA1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000749	0.00312	CbGpPWpGaD
Propofol—GABRA1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000749	0.00312	CbGpPWpGaD
Propofol—GABRA2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000727	0.00304	CbGpPWpGaD
Propofol—GABRA2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000727	0.00304	CbGpPWpGaD
Propofol—GABRB3—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000723	0.00302	CbGpPWpGaD
Propofol—GABRB3—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000723	0.00302	CbGpPWpGaD
Propofol—UGT1A8—Metabolism—CHRM3—nephrolithiasis	0.00071	0.00296	CbGpPWpGaD
Propofol—GABRG2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00071	0.00296	CbGpPWpGaD
Propofol—GABRG2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00071	0.00296	CbGpPWpGaD
Propofol—ALB—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.000699	0.00292	CbGpPWpGaD
Propofol—GABRA1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000696	0.00291	CbGpPWpGaD
Propofol—GABRA1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000696	0.00291	CbGpPWpGaD
Propofol—ALB—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000694	0.0029	CbGpPWpGaD
Propofol—ALB—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000694	0.0029	CbGpPWpGaD
Propofol—GABRB2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00062	0.00259	CbGpPWpGaD
Propofol—GABRA1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00062	0.00259	CbGpPWpGaD
Propofol—GABRA1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00062	0.00259	CbGpPWpGaD
Propofol—ALB—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000618	0.00258	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—GRHPR—nephrolithiasis	0.000595	0.00248	CbGpPWpGaD
Propofol—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	0.000589	0.00246	CbGpPWpGaD
Propofol—GABRA2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000582	0.00243	CbGpPWpGaD
Propofol—GABRB3—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000578	0.00241	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—AQP1—nephrolithiasis	0.000573	0.00239	CbGpPWpGaD
Propofol—GABRG2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000567	0.00237	CbGpPWpGaD
Propofol—ALB—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000565	0.00236	CbGpPWpGaD
Propofol—ALB—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000565	0.00236	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—AGXT—nephrolithiasis	0.00053	0.00221	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—CHRM3—nephrolithiasis	0.000518	0.00216	CbGpPWpGaD
Propofol—GABRA1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000496	0.00207	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—GRHPR—nephrolithiasis	0.00047	0.00196	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—GRHPR—nephrolithiasis	0.00047	0.00196	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—APRT—nephrolithiasis	0.000451	0.00188	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—SLC26A1—nephrolithiasis	0.000451	0.00188	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—GRHPR—nephrolithiasis	0.000439	0.00183	CbGpPWpGaD
Propofol—ALB—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000429	0.00179	CbGpPWpGaD
Propofol—ALB—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000429	0.00179	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—AGXT—nephrolithiasis	0.000419	0.00175	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—AGXT—nephrolithiasis	0.000419	0.00175	CbGpPWpGaD
Propofol—ALB—Hemostasis—DGKH—nephrolithiasis	0.00041	0.00171	CbGpPWpGaD
Propofol—ALB—Hemostasis—SLC7A9—nephrolithiasis	0.00041	0.00171	CbGpPWpGaD
Propofol—ALB—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000398	0.00166	CbGpPWpGaD
Propofol—ALB—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000398	0.00166	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—AGXT—nephrolithiasis	0.000391	0.00163	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—GRHPR—nephrolithiasis	0.000362	0.00151	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—APRT—nephrolithiasis	0.000356	0.00149	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—SLC26A1—nephrolithiasis	0.000356	0.00149	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—SLC26A1—nephrolithiasis	0.000356	0.00149	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—APRT—nephrolithiasis	0.000356	0.00149	CbGpPWpGaD
Propofol—ALB—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000355	0.00148	CbGpPWpGaD
Propofol—ALB—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000355	0.00148	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—APRT—nephrolithiasis	0.000332	0.00139	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—SLC26A1—nephrolithiasis	0.000332	0.00139	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—AGXT—nephrolithiasis	0.000323	0.00135	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—AQP1—nephrolithiasis	0.000321	0.00134	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—GRHPR—nephrolithiasis	0.000292	0.00122	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—CHRM3—nephrolithiasis	0.000291	0.00121	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—GRHPR—nephrolithiasis	0.000286	0.0012	CbGpPWpGaD
Propofol—ALB—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000284	0.00118	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—APRT—nephrolithiasis	0.000275	0.00115	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—SLC26A1—nephrolithiasis	0.000275	0.00115	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—GRHPR—nephrolithiasis	0.00027	0.00113	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—AGXT—nephrolithiasis	0.000261	0.00109	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—AGXT—nephrolithiasis	0.000255	0.00107	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—AQP1—nephrolithiasis	0.000254	0.00106	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—AQP1—nephrolithiasis	0.000254	0.00106	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—GRHPR—nephrolithiasis	0.000248	0.00103	CbGpPWpGaD
Propofol—ALB—Metabolism—GRHPR—nephrolithiasis	0.000246	0.00103	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—AGXT—nephrolithiasis	0.000241	0.001	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—AQP1—nephrolithiasis	0.000237	0.000989	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—CHRM3—nephrolithiasis	0.00023	0.000959	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—CHRM3—nephrolithiasis	0.00023	0.000959	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—SLC26A1—nephrolithiasis	0.000222	0.000925	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—APRT—nephrolithiasis	0.000222	0.000925	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—GRHPR—nephrolithiasis	0.000221	0.000923	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—AGXT—nephrolithiasis	0.000221	0.000921	CbGpPWpGaD
Propofol—ALB—Metabolism—AGXT—nephrolithiasis	0.000219	0.000916	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—APRT—nephrolithiasis	0.000217	0.000906	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—SLC26A1—nephrolithiasis	0.000217	0.000906	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—CHRM3—nephrolithiasis	0.000214	0.000894	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—SLC26A1—nephrolithiasis	0.000205	0.000854	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—APRT—nephrolithiasis	0.000205	0.000854	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—GRHPR—nephrolithiasis	0.000203	0.000849	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—GRHPR—nephrolithiasis	0.000202	0.000841	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—AGXT—nephrolithiasis	0.000197	0.000822	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—AQP1—nephrolithiasis	0.000196	0.000817	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—SLC26A1—nephrolithiasis	0.000188	0.000783	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—APRT—nephrolithiasis	0.000188	0.000783	CbGpPWpGaD
Propofol—ALB—Metabolism—SLC26A1—nephrolithiasis	0.000187	0.000779	CbGpPWpGaD
Propofol—ALB—Metabolism—APRT—nephrolithiasis	0.000187	0.000779	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—AGXT—nephrolithiasis	0.000181	0.000756	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—AGXT—nephrolithiasis	0.00018	0.00075	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—CHRM3—nephrolithiasis	0.000177	0.000739	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—GRHPR—nephrolithiasis	0.000172	0.000719	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—APRT—nephrolithiasis	0.000167	0.000699	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—SLC26A1—nephrolithiasis	0.000167	0.000699	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—AQP1—nephrolithiasis	0.000158	0.000659	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—AQP1—nephrolithiasis	0.000155	0.000646	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—APRT—nephrolithiasis	0.000154	0.000643	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—SLC26A1—nephrolithiasis	0.000154	0.000643	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—AGXT—nephrolithiasis	0.000153	0.000641	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—APRT—nephrolithiasis	0.000153	0.000638	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—SLC26A1—nephrolithiasis	0.000153	0.000638	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—AQP1—nephrolithiasis	0.000146	0.000609	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—CHRM3—nephrolithiasis	0.000143	0.000596	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—CHRM3—nephrolithiasis	0.00014	0.000584	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—AQP1—nephrolithiasis	0.000134	0.000558	CbGpPWpGaD
Propofol—ALB—Metabolism—AQP1—nephrolithiasis	0.000133	0.000555	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—GRHPR—nephrolithiasis	0.000133	0.000555	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—CHRM3—nephrolithiasis	0.000132	0.000551	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—APRT—nephrolithiasis	0.000131	0.000545	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—SLC26A1—nephrolithiasis	0.000131	0.000545	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—CHRM3—nephrolithiasis	0.000121	0.000505	CbGpPWpGaD
Propofol—ALB—Metabolism—CHRM3—nephrolithiasis	0.00012	0.000502	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—AQP1—nephrolithiasis	0.000119	0.000498	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—AGXT—nephrolithiasis	0.000118	0.000495	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—AQP1—nephrolithiasis	0.00011	0.000458	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—AQP1—nephrolithiasis	0.000109	0.000454	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—CHRM3—nephrolithiasis	0.000108	0.000451	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—APRT—nephrolithiasis	0.000101	0.00042	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	0.000101	0.00042	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—CHRM3—nephrolithiasis	9.93e-05	0.000414	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—CHRM3—nephrolithiasis	9.84e-05	0.000411	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—AQP1—nephrolithiasis	9.3e-05	0.000388	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—CHRM3—nephrolithiasis	8.41e-05	0.000351	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—AQP1—nephrolithiasis	7.18e-05	0.0003	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—CHRM3—nephrolithiasis	6.49e-05	0.000271	CbGpPWpGaD
